Tag

Caladrius Biosciences Inc.

DNA

Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences
healthcare

Caladrius Biosciences Awarded $12.2-M Grant from CIRM in Support of Phase 2 Clinical Trial of CLBS03 to Treat Type 1 Diabetes
Innovation

Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes